{"id":87873,"date":"2022-08-12T00:00:00","date_gmt":"2022-08-12T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2022\/08\/12\/symptoms-linger-for-some-children-after-acute-covid-19-mis-c\/"},"modified":"2022-08-15T21:28:15","modified_gmt":"2022-08-15T21:28:15","slug":"symptoms-linger-for-some-children-after-acute-covid-19-mis-c","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2022\/08\/12\/symptoms-linger-for-some-children-after-acute-covid-19-mis-c\/","title":{"rendered":"Symptoms Linger for Some Children After Acute COVID-19, MIS-C"},"content":{"rendered":"<h3>\n<p>Persistent symptoms or activity impairment seen in more than 25 percent of children hospitalized with COVID-19, MIS-C<\/p>\n<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>FRIDAY, Aug. 12, 2022 (HealthDay News) &#8212; At least two months after hospitalization with acute COVID-19 or multisystem inflammatory syndrome in children (MIS-C), more than 25 percent experience persistent symptoms or activity impairment, according to a study published online Aug. 12 in <em>Pediatrics<\/em>.\n<\/p>\n<p>\n\tAline B. Maddux, M.D., from the University of Colorado School of Medicine and Children&#8217;s Hospital Colorado in Aurora, and colleagues conducted a multicenter, prospective observational cohort study in 25 U.S. pediatric hospitals to examine risk factors for postdischarge sequelae in children and adolescents (aged younger than 21 years) after hospitalization for acute COVID-19 or MIS-C. Two- to four-month survey data were available for 76.8 percent of 155 patients with acute COVID-19 and 78.8 percent of 203 patients with MIS-C.\n<\/p>\n<p>\n\tThe researchers found that 11 and 8 percent of patients with acute COVID-19 and MIS-C, respectively, had a readmission. Of those with acute COVID-19, 26.9 percent had persistent symptoms or activity impairment (22.7 and 14.3 percent, respectively), while 30.0 percent of those with MIS-C had persistent symptoms or activity impairment (20.0 and 21.3 percent, respectively). Persistent symptoms and activity impairment were associated with more organ systems involved among patients with acute COVID-19 (adjusted risk ratios, 1.29 and 1.37, respectively). Persistent symptoms occurred more often among patients with MIS-C and preexisting respiratory conditions, while activity impairment was more frequent among those with obesity (adjusted risk ratios, 3.09 and 2.52, respectively). New morbidities were rarely observed (9 and 1 percent among those with COVID-19 and MIS-C, respectively).\n<\/p>\n<p>\n\t&#8220;These findings highlight the importance of postdischarge follow-up of these severely ill patients,&#8221; the authors write.<strong><\/strong>\n<\/p>\n<p>\n\t<a href=\"https:\/\/publications.aap.org\/pediatrics\/article\/doi\/10.1542\/peds.2022-057798\/188356\/Health-Impairments-in-Children-and-Adolescents\" target=\"_blank\" rel=\"noopener\">Abstract\/Full Text<\/a>\n<\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2022 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Persistent symptoms or activity impairment seen in more than 25 percent of children hospitalized with COVID-19, MIS-C<\/p>\n","protected":false},"author":6,"featured_media":87954,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-87873","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/87873","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=87873"}],"version-history":[{"count":1,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/87873\/revisions"}],"predecessor-version":[{"id":87953,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/87873\/revisions\/87953"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/87954"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=87873"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=87873"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=87873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}